GERN 8-K 2026-11-04

GERON CORP (GERN) 8-K dated 2026-11-04 — accession 0001193125-26-446203.

GERON CORP (GERN) is a biotechnology company listed on US.

GERON CORP filed a 8-K on 2026-11-04. Accession 0001193125-26-446203.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported GERN revenue for 2026-06-30 was $57.5M. Net income was -$16.7M. Revenue was up 10.9% from 2026-03-31 to 2026-06-30. GERN currently screens at market cap $878.9M.

Not investment advice. The GERN SEC hub lists recent forms. The stock page is the research view.